TARPLIN, DOWNS & YOUNG, LLC for VERTEX PHARMACEUTICALS INCORPORATED
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
**see addendum page PL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 1217 - to Repeal the Prevention and Public Health Fund H.R. 2405 and S. 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 FDA User Fee Reauthorizations, drug development policies, accelerated approval S. 3187 - The Food and Drug Administration Safety and Innovation Act (H.R. 3988, H.R. 4087, H.R. 5334, S. 2236, S. 2289, S. 2516) ***, no specific bill, Raising Awareness of Hepatitis C, HHS National Strategy, Raising Awareness of Cystic Fibrosis ***, no specific bill, public health funding for Hepatitis, appropriations for the Department of Health and Human Services, screening guidelines, PDUFA, federal flu policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Budget/Appropriations BUD
budget resolution, health care reform, prevention fund, deficit reduction H.Con.Res. 112, budget resolution for 2013 H.R. 5872, Sequestration Transparency Act of 2012
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. On Finance; |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | Congressman Billy Tauzin |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.